NCT05490576View on ClinicalTrials.gov

Tau And Connectomics In TES Study

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 3, 2023

Primary Completion Date

May 30, 2023

Study Completion Date

December 31, 2024

Conditions
Chronic Traumatic EncephalopathyTraumatic EncephalopathyHead Injury TraumaCognitive ImpairmentNeurodegenerative Diseases
Interventions
RADIATION

[18F] PI-2620 Tau Ligand

Tau binding ligand

Trial Locations (1)

2109

Macquarie Medical Imaging, Macquarie Park

Sponsors
All Listed Sponsors
collaborator

Omniscient Neurotechnology

INDUSTRY

collaborator

Life Molecular Imaging GmbH

INDUSTRY

lead

Macquarie University, Australia

OTHER